Department of Chemistry

portrait of Dr David Spring

Dr David Spring

Trinity College

Groups: Spring group website

Telephone: 01223 336498

E-mail: spring@ch.cam.ac.uk

Our research interests originate from a desire to understand and exploit biological systems using organic synthesis primarily. Listed below are areas of research that we are exploring; for more detailed information visit the Spring Group web pages.

• Diversity-Oriented Synthesis
• Synthetic Methodology: Medium Ring Synthesis and Natural Product Synthesis
• Quorum Sensing
• New Antibiotic Discovery
• Modulation of Protein-Protein Interactions
• Molecular Therapeutics: Chemistry-Driven Drug Discovery

We collaborate with many chemical companies and academic groups around the world. The scientific education of group members in organic synthesis is given a high priority; however, they are encouraged also to learn and perform new techniques relating to their projects with our industrial and academic collaborators. Every effort is made so that group members achieve their career ambitions, usually jobs in academia or the chemical industries.

Selected Publications

For our most recent publications please visit the Spring Group publication page.

Diversity-Oriented Synthesis of Macrocyclic Peptidomimetics. Proc. Natl. Acad. Sci. USA 2011108, 6793-6798.
Better leads come from diversity. Nature 2011470, 43.
Novel and Efficient Copper-Catalysed Synthesis of Nitrogen-Linked Medium-Ring Biaryls. Chem. Eur. J. 201117, 2981-2986.
Chemical Genetics. Chem. Soc. Rev. 201140, 4332-4345.
Diversity-oriented synthesis as a tool for the discovery of novel biologically functional small molecules. Nature Commun. 20101, 80.
Zn2+-Triggered Amide Tautomerization Produces a Highly Zn2+-Selective, Cell-Permeable and Ratiometric Fluorescent Sensor. JACS 2010, 132, 601-610.
Diversity-oriented synthesis of bicyclic and tricyclic alkaloids. Chem. Commun. 201046, 776-778.
The molecular basis of the host response to lipopolysaccharide. Nature Rev. Microbio. 2010, 8, 8-14.
3D small-molecule microarrays. Chem. Commun. 2009, 7107-7109.
Mastering the Chemical Language of Bacteria. Chem. Biol. 2009, 16, 913-914.
The discovery of antibacterial agents using diversity oriented synthesis. Chem. Commun. 2009, 2446-2462.
Synthesis of Unprecedented Scaffold Diversity. Angew. Chem. Int. Ed. 2009, 48, 1194-1196.
Towards quorum-quenching catalytic antibodies. Chem. Commun. 2009, 538-540.
Total Synthesis of Sanguiin H-5. Org. Lett. 2008, 10, 2593-2596.
Anti-MRSA Agent Discovery Using Diversity-Oriented Synthesis. Angew. Chem. Int. Ed. 2008, 47, 2808-2812.

 


General


 

For more detailed information please visit the Spring Group web pages.

Research Interests


 

For more detailed information please visit the Spring Group research pages.

Teaching


 

If you are looking for the teaching material from my lecture courses, then please go to the CamTools website.

Personal


 

For more detailed information please visit here.

Publications

 

For a list of all our publications please visit the Spring Group publication page.

Publications

The molecular basis of the host response to lipopolysaccharide
CE Bryant, DR Spring, M Gangloff, NJ Gay - Nature Reviews Microbiology (2010) 8, 8
(DOI: 10.1038/nrmicro2266)
Synthesis of highly substituted symmetrical 1,3-dienes via tandem carbocupration and organocuprate oxidation
SJ Aves, KG Pike, DR Spring - Synlett (2010), 2839
Ratiometric fluorescent and colorimetric sensors for Cu2+ based on 4,5-disubstituted-1,8-naphthalimide and sensing cyanide via Cu2+ displacement approach
Z Xu, J Pan, DR Spring, J Cui, J Yoon - Tetrahedron (2010) 66, 1678
Diversity-oriented synthesis as a tool for the discovery of novel biologically active small molecules.
WR Galloway, A Isidro-Llobet, DR Spring - Nat Commun (2010) 1, 80
(DOI: 10.1038/ncomms1081)
3D small-molecule microarrays.
DM Marsden, RL Nicholson, M Ladlow, DR Spring - Chemical Communications (2009), 7107
(DOI: 10.1039/b913665g)
Synthesis of biaryl-containing medium-ring systems by organocuprate oxidation: Applications in the total synthesis of ellagitannin natural products
XB Su, GL Thomas, WRJD Galloway, DS Surry, RJ Spandl, DR Spring - Synthesis (2009), 3880
(DOI: 10.1055/s-0029-1218154)
Mastering the chemical language of bacteria.
WRJD Galloway, JT Hodgkinson, M Welch, DR Spring - Chemistry and Biology (2009) 16, 913
(DOI: 10.1016/j.chembiol.2009.09.006)
The discovery of antibacterial agents using diversity-oriented synthesis
WRJD Galloway, A Bender, M Welch, DR Spring - Chemical Communications (2009), 2446
(DOI: 10.1039/b816852k)
Is synthesis the main hurdle for the generation of diversity in compound libraries for screening?
WRJD Galloway, DR Spring - Expert Opinion on Drug Discovery (2009) 4, 467
(DOI: 10.1517/17460440902916606)
Fluoride-free cross coupling using vinyldisiloxanes.
HF Sore, CM Boehner, SJF MacDonald, D Norton, DJ Foxd, DR Spring - Organic and Biomolecular Chemistry (2009) 7, 1068
(DOI: 10.1039/b900852g)
Towards quorum-quenching catalytic antibodies
PB Kapadnis, E Hall, M Ramstedt, WRJD Galloway, M Welch, DR Spring - Chemical Communications (2009), 538
(DOI: 10.1039/b819819e)
Synthesis of unprecedented scaffold diversity
WRJD Galloway, M Diaz-Gavilan, A Isidro-Llobet, DR Spring - Angew Chem Int Ed Engl (2009) 48, 1194
(DOI: 10.1002/anie.200805452)
Using chemical probes to investigate the sub-inhibitory effects of azithromycin
FG Glansdorp, RJ Spandl, JE Swatton, O Loiseleur, M Welch, DR Spring - Organic and Biomolecular Chemistry (2008) 6, 4120
(DOI: 10.1039/b813157k)
Identification of an anti-MRSA dihydrofolate reductase inhibitor from a diversity-oriented synthesis
EE Wyatt, WRJD Galloway, GL Thomas, M Welch, O Loiseleur, AT Plowright, DR Spring - Chemical Communications (2008), 4962
(DOI: 10.1039/b812901k)
Synthesis of a biotin-labeled quorum-sensing molecule: Towards a general method for target identification
RJ Spandl, RL Nicholson, DM Marsden, JT Hodgkinson, XB Su, GL Thomas, GPC Salmond, M Welch, DR Spring - Synlett (2008), 2122
(DOI: 10.1055/s-2008-1077978)
Gemmacin B: Bringing diversity back into focus
A Robinson, GL Thomas, RJ Spandl, M Welch, DR Spring - Organic and Biomolecular Chemistry (2008) 6, 2978
(DOI: 10.1039/b809038f)
ORGN 157-Diversity oriented synthesis: From linear aminoalkenes to complex cyclic scaffolds
M Diaz-Gavilan, K O'Connell, F Benfatti, DR Spring - ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY (2008) 236
BIOL 47-Synthesis of a transition-state analog for the hydrolysis of N-acyl homoserine lactones
PB Kapadnis, E Hall, M Welch, DR Spring - ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY (2008) 236
Exploiting domino enyne metathesis mechanisms for skeletal diversity generation
RJ Spandl, H Rudyk, DR Spring - Chemical Communications (2008), 3001
(DOI: 10.1039/b807278g)
Total synthesis of sanguiin H-5.
XB Su, DS Surry, RJ Spandl, DR Spring - Organic Letters (2008) 10, 2593
(DOI: 10.1021/ol8009545)
2-Methoxycyclopentyl analogues of a Pseudomonas aeruginosa quorum sensing modulator.
LYW Lee, T Hupfield, RL Nicholson, JT Hodgkinson, XB Su, GL Thomas, GPC Salmond, M Welch, DR Spring - Molecular BioSystems (2008) 4, 505
(DOI: 10.1039/b801563e)
Diversity-oriented synthesis; A spectrum of approaches and results
RJ Spandl, A Bender, DR Spring - Organic and Biomolecular Chemistry (2008) 6, 1149
(DOI: 10.1039/b719372f)
Identification of an anti-MRSA dihydrofolate reductase inhibitor from a diversity-oriented synthesis.
EE Wyatt, WR Galloway, GL Thomas, M Welch, O Loiseleur, AT Plowright, DR Spring - Chemical communications (Cambridge, England) (2008), 4962
Diversity-oriented synthesis.
RJ Spandl, M Diaz-Gavilan, KMG O'Connell, GL Thomas, DR Spring - Chemical Record (2008) 8, 129
(DOI: 10.1002/tcr.20144)
Anti-MRSA agent discovery using diversity-oriented synthesis
GL Thomas, RJ Spandl, FG Glansdorp, M Welch, A Bender, J Cockfield, JA Lindsay, C Bryant, DFJ Brown, O Loiseleur, H Rudyk, M Ladlow, DR Spring - Angew Chem Int Ed Engl (2008) 47, 2808
(DOI: 10.1002/anie.200705415)

Funding


Funding: 

 

We are extremely fortunate, and grateful, that this research is funded by research councils (A*Star, BBSRC, DAAD, EPSRC, ERC, EU, MRC), charities (CRUK, Cambridge Trusts, Frances and Augustus Newman Foundation, Isaac Newton Trust, Wellcome Trust) and industry (AZ, Bayer Schering, GSK, Lilly, Pfizer, Syngenta, UCB).

CV

CV: 

 

For more detailed information please visit here.